HRA004740
Title:
Single-cell profiling revealed tumor heterogeneity and microenvironment in surgically resectable esophageal squamous cell carcinoma with neoadjuvant chemoimmunotherapy
Release date:
2024-10-25
Description:
This study enrolled 22 patients diagnosed with stage II to IV ESCC, of whom 20 underwent neoadjuvant tislelizumab combined with chemotherapy before surgical removal and two were treated with camrelizumab plus chemotherapy before surgery. The dataset performed single-cell transcriptomic data of a total of 259,003 cells derived from 22 baseline and 24 post-NAT treatment samples of 22 stage II/III resectable ESCC patients.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
esophageal basaloid squamous cell carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
PRJCA016745
Contact person:
Lu Qiang
Email:
luqiang@fmmu.edu.cn
Description:
DAC of PRJCA016745
Individuals & samples
Submitter:   Lu Qiang / luqiang@fmmu.edu.cn
Organization:   Air Force Medical University
Submission date:   2023-05-31
Requests:   3